27/08/2026
Chayote is more than just a mild green squash. Researchers have explored its potential role in metabolic health, including human studies involving older adults with metabolic syndrome. In one six-month, placebo-controlled study, participants who received a concentrated preparation made from Sechium edule experienced reductions in both systolic and diastolic blood pressure, along with an increase in HDL cholesterol. Other research has reported possible improvements in HbA1c, oxidative stress, and certain inflammatory markers.
These findings make chayote an interesting subject in nutrition and metabolic wellness research. However, an important distinction is often overlooked: the studies used concentrated chayote preparations or powders rather than ordinary portions of cooked chayote eaten as part of a normal diet. The results therefore should not automatically be interpreted as evidence that simply adding chayote to meals will produce the same effects.
Claims involving fatty liver disease and cancer require even greater caution. A small exploratory human study reported reductions in the liver enzymes ALT and AST, but these findings do not demonstrate that chayote can reverse fatty liver disease. Laboratory experiments have also found that certain chayote extracts may inhibit the growth of some cancer cells and promote apoptosis. However, those effects were observed in laboratory cell models, not in cancer patients.
For that reason, chayote should be viewed as a nutritious food being studied for potential health effects, not as a proven treatment for disease.